NPCE Q3 2023 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena

NPCENeuroPace, Inc.

$482M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$16M+47.2% YoY

Gross Profit

$12M74.5% margin

Operating Income

-$6M-36.2% margin

Net Income

-$7M-44.2% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

-0.5%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$99M

Total Liabilities

$83M

Stockholders' Equity

$16M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$11M	+47.2%
Gross Profit	$12M	$8M	+53.6%
Operating Income	-$6M	-$10M	+41.7%
Net Income	-$7M	-$12M	+38.4%